Related Experiment Video
Updated: Jun 20, 2026

Assaying Proteasomal Degradation in a Cell-free System in Plants
Published on: March 26, 2014
Proteasomal degradation of beta-carotene metabolite--modified proteins
Olaf Sommerburg1, Nicole Karius, Werner Siems
1Department of Pediatric Pulmonology, Children's University Hospital III, Heidelberg, Germany.
Abstract:
Free radical attack on beta-carotene results in the formation of high amounts of carotene breakdown products (CBPs) having biological activities. As several of the CBPs are reactive aldehydes, it has to be considered that these compounds are able to modify proteins. Therefore, the aim of the study was to investigate whether CBP-modification of proteins is leading to damaged proteins recognized and degraded by the proteasomal system. We used the model proteins tau and ferritin to test whether CBPs will modify them and whether such modifications lead to enhanced proteasomal degradation. To modify proteins, we used crude CBPs as a mixture obtained after hypochloric acid derived BC degradation, as well as several single compounds, as apo8'-carotenal, retinal, or beta-ionone. The majority of the CBPs found in our reaction mixture are well known metabolites as described earlier after BC degradation using different oxidants. CBPs are able to modify proteins, and in in vitro studies, we were able to demonstrate that the 20S proteasome is able to recognize and degrade CBP-modified proteins preferentially. In testing the proteolytic response of HT22 cells toward CBPs, we could demonstrate an enhanced protein turnover, which is sensitive to lactacystin. Interestingly, the proteasomal activity is resistant to treatment with CBP. On the other hand, we were able to demonstrate that supraphysiological levels of CBPs might lead to the formation of protein-CBP-adducts that are able to inhibit the proteasome. Therefore, the removal of CBP-modified proteins seems to be catalyzed by the proteasomal system and is effective, if the formation of CBPs is not overwhelming and leading to protein aggregates.
Insights
Carotene breakdown products (CBPs) modify proteins, leading to their preferential degradation by the proteasome. However, excessive CBPs can inhibit proteasome function, highlighting a balance in cellular protein turnover.
Area of Science:
- Biochemistry
- Cell Biology
- Oxidative Stress
Background:
- Beta-carotene degradation yields biologically active carotene breakdown products (CBPs).
- Several CBPs are reactive aldehydes capable of modifying proteins.
- Protein modification by CBPs raises questions about cellular damage and repair mechanisms.
Purpose of the Study:
- To investigate if CBP-modified proteins are recognized and degraded by the proteasomal system.
- To determine the impact of CBP modification on protein turnover in cellular models.
- To assess the effect of CBPs on proteasome activity and potential inhibition.
Main Methods:
- In vitro modification of model proteins (tau, ferritin) using crude CBPs and single CBP compounds.
- Assessment of proteasomal degradation of modified proteins using the 20S proteasome.
- Evaluation of cellular proteolytic response in HT22 cells treated with CBPs.
- Analysis of proteasome activity and inhibition by CBPs and protein-CBP adducts.
Main Results:
- CBPs effectively modify proteins in vitro.
- The 20S proteasome preferentially degrades CBP-modified proteins.
- HT22 cells exhibit enhanced protein turnover sensitive to lactacystin in response to CBPs.
- Supraphysiological CBP levels can form protein-CBP adducts that inhibit proteasome activity.
Conclusions:
- The proteasomal system plays a role in removing CBP-modified proteins.
- Proteasomal degradation of modified proteins is efficient under non-overwhelming CBP conditions.
- High CBP levels can overwhelm the system, leading to protein aggregates and proteasome inhibition.
More Related Videos
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome Structure
The proteasome is an...

